Tranmenxio Iv 500mg Solution for injection/infusion
PDF Leaflet Revision Date: 29 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short term use in hyphaema and hereditary angioedema.
Dosage (summary)
1.0 to 1.5 g IV every 8 hours for traumatic hyphaema; 1.0 - 1.5 g IV 2-3 times daily for hereditary angioedema.
Special Populations
- Renal impairment
Pregnancy & Breastfeeding
Safety not established in pregnancy; caution in breastfeeding.
Key Drug Interactions
- Increased thrombus formation with oestrogens
- Antagonism with thrombolytics
Contraindications
- Hypersensitivity
- Acute thrombosis
- Fibrinolytic conditions
- History of convulsions
Common side effects
- Dizziness
- Visual disturbances
- Nausea
- Vomiting
Counselling Points
- Administer slowly IV
- Monitor for visual disturbances
- Avoid in patients with thromboembolic history
Serious warnings
- Risk of convulsions
- Thromboembolic events
- Care in renal failure
Important Disclaimer
The Tranmenxio Iv 500mg Solution for injection/infusion professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
